Potential drug treatment for particular type of lung-cancer
The effectiveness of cancer treatment is often hampered by cancer cells being heterogeneous. This is…
Browsing: osimertinib
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized,…
Osimertinib improves symptoms in advanced lung cancer patients
Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis of…
FDA approves osimertinib for non-small cell lung cancer
The US Food and Drug Administration has granted accelerated approval to osimertinib (Tagrisso) once daily…